Abdominal Jose F. Botet, MD Carlos Urmacher,
#{149} Charles J. Lightdale, MD #{149} Ann MD #{149} Murray F. Brennan, MD
Preoperative Comparison Fifty
with
patients
proved by means went preoperative scopic
(US);
in 42 of
the patients, dynamic CT of the chest and abdomen was also performed. All results were compared with the findings at pathologic examination of resected specimens. In staging the depth of tumor growth, endoscopic US was significantly more accurate (46 of 50 tumors [92%1) than CT (25 of 42 tumors [60%J) (P < .0003). In staging regional lymph nodes, it was more accurate (44 of 50 patients [88%]) than CT (31 of 42 patients [74%]), but this was not statistically significant. In staging distant metastases,
rate
however,
CT was
(38 of 42 patients
doscopic
US
more
[90%J)
accu-
than
(35 of 50 patients
en-
[70%])
(P < .016). The highest concordance with surgical and pathologic findings in overall stage (36 of 42 tumors [86%]) occurred with the combined use
of CT
was
and
endoscopic
US,
significantly
more
accurate
I
From
the
#{149} Hans
of Medical
of the esophagus is a relatively uncommon neoplasm in the United States, and approximately 10,000 new cases were expected to be diagnosed in 1990 (1). ARCINOMA
This carcinoma
now
accounts
for
about 1 % of all malignancies and 2% of all cancer-related deaths. A cumulative literature review by Earlam and Cunha-Melo in 1980, including 83,783 surgical
cases,
reported
an
overall
5-year survival rate of 4% (2). In the United States, most patients have advanced disease at the time of initial diagnosis (3). The prognosis after surgical resection is closely related to pathologic stage (4). This
prospective
study
was
de-
signed to compare the accuracy of endoscopic ultrasonography (US) in preoperative clinical staging of esophageal cancer with that of dynamic computed tomography (CT) with use of pathologic examination of resected specimens as a standard.
Study
181:419-425
Departments
C
PATIENTS
Computed tomography (CT), preoperative #{149} Endoscopy, 718.12981 #{149} Esophagus, neoplasms, 71.321 #{149} Lymphatic system, neoplasms, 996.8323 #{149} Ultrasound (US), comparative studies #{149} Ultrasound (US), tissue characterization, 718.321 1991;
PhD
than
terms:
Radiology
G. Zauber,
which
use of CT alone (27 of 42 tumors [64%]) (P < .008).
Index
Gastrointestinal
Staging ofEsophageal ofEndoscopic US and
esophageal cancer of biopsy understaging with endo-
ultrasonography
and
Imaging
(J.F.B.), Medicine, Gastroenterology Service (C.J.L., HG.), Epidemiology and Biostatistics (A.G.Z.), Pathology (CU.), and Surgery (M.F.B.), Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, 1275 York Aye, New York, NY 10021. From the 1988 RSNA scientific assembly. Received March 6, 1991; revision requested April 24; revision received June 18; accepted June 19. Address reprint requests toJ.F.B. 0 RSNA, 1991
See also the article by Botet et al (pp 426-432) and the editorial by Baker and Kopecky (pp 342-343) in this issue.
AND
METHODS
Group
Radiology
Gerdes,
MD
Cancer: CT’
Dynamic
screening chemistry
hematologic tests.
tests,
and
The study group consisted and 14 female patients with
blood
of 36 male a mean age of
60.3 years (median age, 60 years). They had 12 epidermoid carcinomas and 38 adenocarcinomas. Location of the tumor in
the esophagus was divided into upper (if the tumor was 10-19 cm from the incisors), middle lower
One
(20-29 cm from the incisors), and (more than 30 cm from the incisors).
tumor
(2%)
was
in the
upper
third,
eight tumors (16%) were in the middle third, and 41 tumors (82%) were in the lower third of the esophagus. All imaging findings were compared
with those obtained at surgery logic evaluation of the resected
and pathospecimens
with regard to depth of penetration of the tumor through the esophageal wall, regional lymph node metastasis, and distant metastasis, according to the 1988 staging classification of the American Joint Committee on Cancer (AJCC) (Tables 1, 2) (5).
Endoscopic
US
We used a commercially available US endoscope with a 7.5-MHz radial transducer (GF-UM2; Olympus, Lake Success, NY) and one with a switchable 7.5- and 12-MHz transducer (GF-UM3, Olympus).
The scanning
plane
of these
instruments
1988, 50 consecutive patients who underwent surgery for epidermoid carcinoma or adenocarcinoma of the esophagus enrolled in a prospective study for preoperative evaluation and staging of their disease. All patients were selected with the understanding that surgery was planned for either paffiation or attempt at cure.
was orthogonal to the axis of the insertion tube, and the field of view was 360#{176}. The images were obtained in real time with a scanning speed of 10 revolutions per second. A balloon with a radius of 1.5 cm, which could be filled with water for better acoustical contact, was placed over the transducer head. The maximum resolution with the 12-MHz transducer was less than
Evaluation
0.5
Between
December
and staging
1986 and December
included
endos-
copy,
endoscopic US, and, in 42 of the 50 patients, dynamic CT of the chest and abdomen. Eight patients had previously Un-
dergone
non-contrast
material-enhanced
CT performed elsewhere. Their scans were not included in our study because we considered it essential to have standard, high-quality CT scans for comparison. All endoscopic US scans were obtamed prior to dynamic CT. All CT scans
were
interpreted
by radiologists
rable experience who results of endoscopic also included physical
mm,
and
with
the
7.5-MHz
transducer,
1 .0 mm. The scanning radius was a maximum of 7 cm at 7.5 MHz and was reduced to 3 cm at 12 MHz. The instrument was introduced by an endoscopist with a method similar to the method used with conventional endoscope and was advanced to the gastric antrum. Sonographic evaluation was performed as the instrument was withdrawn. Anatomic land-
a
of compa-
were blinded to the US. Clinical staging examination,
Abbreviations:
mittee
on Cancer,
AJCC
=
American
CI = confidence
Joint Corninterval. 419
marks
(6) were
guide
the
used
by the radiologist
positioning
Images were vals but were
of the
not obtained chosen during
to document
amination
to
Table 1 AJCC Staging
endoscope. at fixed interreal-time cx-
the maximum
US.
Five
layers
of alternating
ies,
the
first
Primary
two
layers
to the
balloon
Regionallymph
Distant
(adventitia)
through
the
as T3 (Fig 3a), and
fifth
TX TO
Primary tumor cannot No evidence of primary
Tis
Carcinoma
Ti T2 T3 T4
Tumor Tumor Tumor Tumor
NX NO Ni
Regional lymph nodes cannot be assessed No regional lymph node metastasis Regional lymph node metastasis
MX
Presence
in situ
invades invades invades invades
lamina propria or submucosa muscularis propria adventitia adjacent structures
metastasis/M of distant
metastasis
cannot
be
assessed MO Mi *
In the cervical
distant.
In the
all others,
esophagus,
thoracic
including
regional
esophagus,
lymph and
nodes
are the supraclavicular
lymph nodes are mediastinal
regional
supraclavicular
No distant metastasis Distant metastasis
celiac
lymph
nodes,
lymph
nodes;
and perigastric
all others
lymph
are
nodes;
are distant.
2
3
layer
invasion
be assessed tumor
nodes/N*
method,
from the upper esophagus to the cardia. Alterations in thickness of individual layers are easily and reproducibly identified. Esophageal cancer was diagnosed as a hypoechoic disruption of the layers. Involvement of any or all of the three inner layers (mucosa and submucosa) was interpreted as TI (Fig 2a), invasion of the fourth layer (muscularis propria) as T2 invasion
Criterion
tumor/T
hyperechoic
correspond
US with the water-filled is approximately 3 mm
2b),
Stage
layers can usually be imOn the basis of in vitro stud-
interface and mucosa, the third layer corresponds to the submucosa, the fourth layer to the muscularis propria, and the fifth layer to the adventitia/serosa (7) (Fig 1). The normal thickness of the esophageal wall, as observed by means of endoscopic
(Fig
Cancer
cx-
tent of disease. Individual layers of the gastrointestinal wall can be visualized with endoscopic and hypoechoic aged in vivo.
of Esophageal
Tissue/Symbol
of 6 5
Table
2
Stage
Grouping
in the TNM
System
Tumor
Node
Metastasis
0
Tis
NO
MO
I
Ti
hA
T2 13 Ti T2 T3 T4
NO NO NO Ni Ni Ni AnyN
AnyT
AnyN
MO MO MO MO MO MO MO Ml
Stage
IIB III
IV
(a) and US scan (b) depict five-layered internal structure normal esophagus. I = mucosa (hyperechoic), 2 = deep mucosa (hypoechoic), (hyperechoic), 4 = muscularis propria (hypoechoic), 5 = adventitial interface and 6 = transducer.
1.
Diagram
b.
a. Figure
(a) Endosonogram shows Ti tumor (t) that dosonogram shows T2 tumor (f) that invades mucosa, row). (c) CT scan of Ti-T2 tumor (t) shows circumferential face.
420
b.
a. Figure
2.
#{149} Radiology
invades
deep
of the
3
wall
of the
= submucosa
(hyperechoic),
C.
the
mucosa, thickening
mucosa
and
and
deep
submucosa
of esophageal
mucosa.
Notice
the
intact
but does
not extend
through
wall
no definite
extension
but
submucosa
(arrow).
the muscularis beyond
(b)
propria
adventitial
November
En-
(arinter-
1991
adjacent
structures
or organs
as T4 (Fig
4a).
The lymphatic drainage areas routinely investigated are the peritumoral area, paratracheal area, aorticopulmonary window, subcarinal area, crural area, celiac axis, splenic vein, portal vein, and gastrohepatic
ligament
nodes were (Ni) if they
(Fig
from surrounding echoic, or if they
characteristics mary cancer The AJCC
a. Figure 3. (a) Endosonograph shows T3 tumor but does not involve any adjacent structure. A
to the
disease
(Fig
diameter. does not
right
b. (T) that
extends
beyond
adventitial
interface
tissue, showed
celiac
7a).
round, or sonographic
lobe
because
axis
as distant
heft
hepatic
The
scanned of distant
hepatic
imaged
lymph
hypo-
similar to those of the pri(Fig 6a, 6b). classifies lymph node me-
tastases
routinely evidence
5). Regional
considered positive for cancer were sharply demarcated
(MI) lobe
was
with endoscopic US for metastasis. Most of the cannot of the
be limited
satisfactorily penetration
LA = left atrium, N = node 1.9 cm in to extension beyond adventitia, but tumor A = aorta, LA = left atrium.
(b) CT scan of T3 tumor. Arrow invade surrounding structures.
= aorta,
points
Tmcsal
I.,.
uodss
TrUcSS-bS’SScMaI
Mds$
uodss
usds
ClUE
b.
a. Figure
shows
4.
(a) Endosonograph T4 tumor (T) that
shows
invades
T4 tumor
the aorta
that
(a) Endosonograph
dosonograph
of malignant
Volume
wall
(arrow).
(b) CT scan
b. 6.
esophageal
Figure aortic
(a).
a. Figure
invades
node
181
1.2 cm
#{149} Number
of benign
node
7 mm
nodes
in diameter
(N)
7 mm
axis nodn
in diameter. (arrow). Note that
5. Lymphatic drainage of the esophagus. Endoscopic US can enable evaluation of all nodes depicted. Jut. = internal.
C.
Note that they they are round
are elongated and hypoechoic
and hyperechoic (at 12 MHz).
(at 12 MHz). (b) En(c) CT scan shows para-
in diameter.
2
Radiology
#{149} 421
of high-frequency
ultrasound.
metastases
be evaluated
cannot
Pulmonary with
en-
doscopic US. In nine tumors, no difference in staging resulted from examination with both 7.5and 12-MHz transducers. The 12-MHz transducer did provide increased detail of the esophageal wall but did not result in any change in evaluation N and M was best assessed
MHz
transducer
depth
of field.
Dynamic
because
of
with the 7.5of the greater
of Chest
CT
Upper
of T. Staging
and
Abdomen
This technique was performed proximately 150-200 mL of 60%
with apiodinated
contrast material given intravenously with a commercially available injector (Mark V; Medrad, Pittsburgh) at a rate of 1.0 mL/sec for the first 60 seconds and then at 0.7 mL/ sec
for
the
remainder
all 42 patients
CT, scans
of the
who
were
underwent dynamic by means of a
International,
Ohio)
with
tions
10-mm-thick
from
the
(GE 9800: or 1200
Highland margin
to the thoracic inlet. These received 200 mL of diluted
GE SX:
Heights,
contiguous
inferior
sec-
of the
liver
patients also diatrizoate
meglumine (Gastrografin; Bristol-Myers Squibb, Princeton, NJ), which was administered orally, to minimize contrast inter-
face
artifacts.
tention
We chose
or change
patients during The thickness wall is variable
the
not
to use gas dis-
position
of these
or after dynamic CT. of the normal esophageal because of the distensibil-
ity of its lumen. We used 5 mm as the upper limits of normal; any increase beyond this was considered abnormal. The thickness of individual layers of the esophageal
wall by
cannot means
be determined of CT.
The
with
following
(Fig
cent
3b); and structures
T4,
wall greater of the outer
than 15 margin
tumor invasion of adjasuch as the trachea, aortic
pericardium, or vertebral body (Fig 4b). Lymph nodes greater than 10 mm in diameter were considered abnormal, a widely used standard (Fig 6c). The drain-
age
areas
examined
were
identical
those examined at endoscopic determined according to the
Note
relationship
metastatic
US. AJCC
to M was classifi-
cation (eg, metastasis to any organ, including lung, or nonregional lymph nodes such as mesenteric or celiac axis nodes [Fig
racoabdominal patients with esophagus agectomy. pect in the sected, identified
underwent Lymph diagnostic
for
Pathologic
Procedures lesions of the upunderwent right
#{149} Radiology
Of the 38 30 underwent
of a combined
(arrow) arteries
9 mm
in diameter
in the
celiac
(b) CT scan of possible
(ART).
attempted.
whereas eight lesions of the distal
nodes
transhiatal identified studies were
esophas susre-
nodes modali-
not
in the were ob-
The resected specimens were examined with special attention to the depth of invasion of the esophageal wall as well as to evidence of invasion into adjacent struc-
tho-
Figure operative ELIS
8.
=
Diagnostic staging
algorithm
of
endoscopic
esophageal
for the precancer.
US.
tures and organs. All peritumoral and resected lymph nodes were examined. Their diameters ranged from 3 mm to 2.6 cm.
Statistical
dent on CT scans in two patients biopsy samples were not obtained
Methods
in whom at sur-
gery.
The
percentage of cases in which endoscopic US findings were in agreement or concordant with the pathologic classification after surgery is given for T, N, and stage in Tables 3-5. A 95% confidence interval (CI) about the percentage of concordant findings is also given, as are the percentage of CT findings concordant with pathologic examination and the concomitant 95% CI. The McNemar test (8,9) for matched was used significant centage
ings
were
pairs with to assess
continuity whether
correction a statistically
difference existed in the of cases in which pathologic
concordant
Surgical
422
aggressively
(HEP)
Examination
findings in the both endoscopic determination
by means
hepatic
node
confirmation.
findings comparisons
exploration
was
samples of metastasis or upper abdomen
dant with statistical
and laparotomy. distal lesions,
metastatic
and
as were other suspected by use of the imaging
ties. Biopsy mediastinum tamed
approach, localized
7b]).
with
splenic
Diagnosis
US and pathologic
thoracotomy patients
to
lesions.
doscopic in which
The 12 patients with per or middle esophagus
of Mi
certainty criteria
therefore were used to determine the T component. It was not possible to differentiate TI from T2 disease. TI and T2 disease was thickening of the wall greater than 5 mm and less than 15 mm (Fig 2c); T3, thickening of the mm with irregularity
axis.
b. (a) Endosonograph
7.
In
obtained
commercially available unit Medical Systems, Milwaukee;
Picker
injection.
a. Figure
with the
findings
percentage findings at dynamic were
42 patients US and of whether
These on
who underwent CT. Also, in our endoscopic US
respect to concordance of TI and T2 were
combined
CT
follow-up
because
between confirmed
cannot
enable
TI and lung
dif-
T2. Clinical
metastases
2 test (8) was also used a significant difference ex-
are
at pathologic test gave
examination. similar results
test for the binomial distribution (P = .5); only the McNemar given
in the
The as the
results
text.
at en-
and CT differ with for T, the categories ferentiation
findings McNemar testing
perfind-
McNemar whether
isted in direction, either overstaging or understaging, in the patients in whom findings at endoscopic US were discordant with findings at pathologic examination and whether such direction existed in findings at dynamic CT compared with
exact
of cases were concorCT. based
The to test
cvi-
RESULTS Tumor
Growth
In 46 of 50 patients with esophageal cancer (92%), endoscopic US findings were concordant with pathologic findings for T (95% CI = 84%, 100%) (Table 3). When Ti and T2 classifications were combined, findings at endoscopic US were concordant with findings at pathologic examination for
November
1991
Invasion
in Esophageal
Findings
Dynamic
CT
.
versus
Cancer. Concordance of with Pathologic Oassification
Findings
Endoscopic Pathologic
Classification of Tumor
TO
Ti
T2
2*
j
Ti T2 T3
Note.-Numbers
are
of tumors.
number
Findings
were
concordant
in 46 of 50 tumors
t Findings
were
concordant
in 25 of42
US and dynamic
scopic
Table
.
T4
1 19*
(92%). tumors(60%).
Endoscopic Dynamic
US 13
2*
T4 *
TO
1 1 23
Ti
CT
T2
T3
14
it it 1
2 1 16t 10
7t
1 I
1
.
P
.0003 in 42 patients